SQZ Biotechnologies
formerly SQZ BiotechClosedWatertown, United States · Founded 2013 · $166.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- sqzbiotech.com
- Total Funding
- $166.0M
- Last Round
- $65.0M Series DMay 2020
- Rounds
- 4
About
SQZ Biotechnologies was a Watertown, Massachusetts-based clinical-stage biotechnology company spun out of MIT that developed Cell Squeeze, a microfluidic cell-engineering platform used to create cell therapies for cancer and other diseases. After halting its lead antigen-presenting cell therapy program in 2023, SQZ's shareholders approved a plan in February 2024 to sell substantially all of its assets to STEMCELL Technologies for roughly $11.8 million and dissolve the company, a process completed in March 2024.
Summary
SQZ Biotechnologies is a Biotech company based in Watertown, United States, founded in 2013. It has raised $166.0M in total across 4 rounds, most recently a $65.0M Series D round in May 2020. Investors include Polaris Partners, Temasek and GV.
Funding History
May 2020
Sign up to see all 4 rounds
Series A through Series D — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sqz-biotechnologies"><img src="https://indexed.vc/api/badge/company/sqz-biotechnologies" alt="SQZ Biotechnologies on Indexed.vc" width="260" height="76" /></a>